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the allogenic cartilage cells were not observed. Histological analysis of
the biopsy specimens rated the repair tissue as hyaline-like in 15.3%, as
mixed tissue in 46.2%, as ﬁbrocartilage in 30.8% and as ﬁbrous in 7.7%.
Conclusions: The results of this pilot study show that the alginate-
based scaffold containing mature human allogenic chondrocytes provides
clinical and histological outcomes equal to those of other cartilage repair
techniques.
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Purpose: To study muscle strength and functional performance in pa-
tients with anterior cruciate ligament (ACL) injury with or without surgical
reconstruction 2 to 5 years after injury. Good muscle function is important
in preventing early-onset osteoarthritis (OA), but the role of reconstructive
surgery in restoring muscle function is unclear.
Methods: 54 patients (mean age at follow up 30 years, range 20−39,
28% women), out of 121 patients with ACL injury included in a randomized
controlled trial on training and surgical reconstruction vs. training only
(the KANON study, ISRCTN84752559), were assessed 3 years (SD 0.9)
after injury with reliable, valid and responsive test batteries for strength
(knee extension, knee ﬂexion, leg press) and hop performance (vertical
jump, one-leg hop, side hop). The Limb Symmetry Index (LSI, injured leg
divided by uninjured and multiplied by 100) value, and absolute values
were used for comparisons between groups (analysis of variance). An
LSI 90% was considered normal.
Results: There were no differences between the surgical and the non-
surgical treatment groups in muscle strength or functional performance.
Between 44% and 89% of the subjects had normal muscle function in
the single tests, and between 44% and 56% had normal function in the
test batteries.
Conclusions: The lack of differences between patients treated with
training and surgical reconstruction or training only, indicates that re-
constructive surgery is not a prerequisite for restoring muscle function.
Abnormal muscle function, found in about one third or more of the
patients, may be a predictor of future knee OA.
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Purpose: Artiﬁcial joint replacement is approved by OARSI guidelines as
the treatment of hip and knee osteoarthritis (OA) with the highest recom-
mended strength and cost-effectiveness (OA&C 2007, 2008). However,
the aseptic loosening induced by wear particles from the polyethylene
(PE) liner remains as the fatal problem limiting their longevity and clinical
success, despite contraptions such as cross-linking of the liner and
changes of the femoral head material. We have developed a novel PE
liner with the surface graft of a biocompatible phospholipids polymer,
2-methacryloyloxyethyl phosphorylcholine (MPC), and reported that this
dramatically decreased the wear production in a hip joint simulator
(Nature Mat 2004). This study compared the MPC effect with those of
the liner cross-linking and the femoral head material.
Methods: We prepared PE liners with or without cross-linking (PE &
CLPE) and photoinduced grafting of MPC onto the surfaces (MPC-PE &
MPC-CLPE). The hydrophilicity of the surface was determined by the
contact angle of a water drop, and the friction torque was measured
against cobalt-chromium alloy (Co-Cr) or alumina ceramic femoral head.
The wear amount was measured as the loss of the liner weight during
5×106 cycles of loading (comparable to 5 to 10 years of physical walking)
in the hip joint simulator. The surfaces of the liners and femoral heads,
as well as the wear particles in the lubricant were analyzed by confocal
scanning laser and electron microscopies, three-dimensional morphom-
etry, and XPS spectroscopy.
Results: The MPC grafting increased hydrophilicity to 5−6 fold and
decreased friction torque to 1/5−1/10, independently of the liner cross-
linking or the femoral head material. Cross-linking by itself altered neither
of them. The loss of liner weight (mg) after 5×106 cycles of loading in the
hip simulator was PE/Co-Cr = 99.6, CLPE/Co-Cr = 18.9, CLPE/alumina =
14.8, MPC-PE/Co-Cr = −5.9, MPC-CLPE/Co-Cr = −6.9, and MPC-
CLPE/alumina = −6.4, indicating that cross-linking caused a signiﬁcant
decrease of wear amount while the femoral head material little affected
it. The MPC grafting abrogated the wear amount, independently of the
liner cross-linking or the femoral head material. The gain of weight in the
MPC-grafted liners was conﬁrmed to be due to water absorption, since it
was similarly seen in all liners with and without MPC grafting during soak
without motion in the lubricant. The suppressions of the wear on the
liner surface and the particle amount in the lubricant by the MPC grafting
were much stronger than those by the cross-linking, independently of the
femoral head material. Interestingly, the particle size from the CLPE liner
was around 0.1mm, while that from PE or MPC-grafted liners was around
10mm.
Conclusions: The MPC grafting increased the surface lubricity and
diminished the wear production, independently of the liner cross-linking or
the femoral head material. In addition, we previously reported that MPC-
grafted wear particles, even if produced, are biologically inert with respect
to phagocytosis by macrophages and subsequent bone resorption. Al-
though cross-linking also suppressed the wear, it did not alter the surface
lubricity but produced submicrometer-sized particles which are known
to induce more catabolic responses above than larger particles. Taken
together, we believe that the MPC grafting surpasses the cross-linking
of the liner and the change of the femoral head materials in extending
longevity of artiﬁcial hip joints. A large-scale clinical trial is now underway.
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Purpose: Total hip joint replacement (THR) is a high volume, effective
but expensive and irreversible intervention, used to treat people with
advanced hip osteoarthritis (OA). In spite of over 40 years of experience
with THR, it is still unclear who should be referred for surgery, when in the
course of arthritis hip replacement should be carried out, or what the de-
terminants of relatively good or bad patient outcomes are. The ‘EUROHIP
consortium’, a multidisciplinary group of health care professionals from
20 centres in 12 European countries, is addressing these questions. As
part of its work, the consortium has developed a prospective cohort of
patients undergoing THR for primary OA. The purpose of this paper is
to describe the variations in disease severity in this cohort, explore the
relationships between clinical and radiographic measures of severity, and
explore some of the determinants of the variation.
Methods: A minimum of 50 consecutive, consenting patients coming
to THR in each participating orthopaedic centre within the EUROHIP
consortium were entered into the study. Baseline data collected included
demographics, employment and educational attainment (surrogates for
socio-economic status), current drug utilisation (a surrogate for co-
morbidities), involvement of other joints, and handedness. In addition,
each subject completed the WOMAC (Likert version 3.1) and the EQ5D
(EUROQoL) questionnaires. Data collected at the time of surgery in-
cluded the prosthesis used and ASA status. We attempted to obtain pre-
operative radiographs from all subjects. These were read by the same
two readers (PD and SW) using both Kellgren and Lawrence grading and
the OARSI atlas.
Results: Data from a total of 1327 subjects has been analysed. The mean
age of the group was 65.7 years, with a wide variation, and there were
more women (53.4%) than men. Most (79%) were ASA status 1 or 2, but
there was widespread use of medications, particularly for cardiovascular
disease and diabetes. Reported disease duration was relatively short,
being 5 years or less in 69.2%. Disease in other joint sites was common.
In 1051 of the 1327 subjects (79%) good quality radiographs were
available for reading and nearly all showed severe OA: the Kellgren and
Lawrence grade was 3 or 4 in 95.8%. However, there was much more
variation in severity assessed by the WOMAC, with many people having
relatively low scores. The mean total WOMAC score was 59.2 (SD 16.1).
